The kallikrein-kinin system: current and future pharmacological targets. [electronic resource]
Producer: 20060503Description: 6-38 p. digitalISSN:- 1347-8613
- Angioedema -- drug therapy
- Angiotensin-Converting Enzyme Inhibitors -- pharmacology
- Animals
- Aprotinin -- pharmacology
- Bradykinin -- analogs & derivatives
- Bradykinin B2 Receptor Antagonists
- Cardiovascular Diseases -- drug therapy
- Complement C1 Inactivator Proteins -- deficiency
- Complement C1 Inhibitor Protein
- Humans
- Inflammation -- drug therapy
- Kallikrein-Kinin System -- drug effects
- Kallikreins -- antagonists & inhibitors
- Kidney Diseases -- drug therapy
- Kinins -- agonists
- Neprilysin -- antagonists & inhibitors
- Peptidyl-Dipeptidase A -- metabolism
- Polymorphism, Genetic
- Pyridines -- pharmacology
- Randomized Controlled Trials as Topic
- Receptor, Bradykinin B1 -- genetics
- Receptor, Bradykinin B2 -- genetics
- Serpins -- deficiency
- Thiazepines -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.